Vaccines and Vaccination
- 4 October 2001
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (14) , 1042-1053
- https://doi.org/10.1056/nejmra011223
Abstract
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has undergone a phase 3 clinical trial,2 indicating that a vaccine will probably be licensed within 5 to 10 years.Traditionally, attenuated vaccines were made by repeated passaging of the infectious agent in tissue culture or animal hosts until its virulence was greatly decreased but its . . .Keywords
This publication has 82 references indexed in Scilit:
- The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old ChildrenNew England Journal of Medicine, 2001
- Cellular immune responses to HIVNature, 2001
- Challenges and opportunities for development of an AIDS vaccineNature, 2001
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Mucosal and Systemic Immune Activation Is Present in Human Immunodeficiency Virus–Exposed Seronegative WomenThe Journal of Infectious Diseases, 2000
- Gene May Promise New Route to Potent VaccinesScience, 1999
- RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 1998
- Applications of molecular microbiology to vaccinologyThe Lancet, 1997
- Rotavirus vaccines: success by reassortment?Science, 1994
- Cellular Immune Responses in the Murine Lung to Local Immunization with Influenza A Virus Glycoproteins in Micelles and Immunostimulatory Complexes (Iscoms)Scandinavian Journal of Immunology, 1988